04/24/2025
6:05 AM | Amylyx Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2025
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2025
6:13 AM | Amylyx Pharmaceuticals (Filer)
| Form ARS | |
04/02/2025
4:22 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:12 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:14 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
3:52 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
11:15 PM | Amylyx Pharmaceuticals (Filer)
| Form EFFECT | |
03/24/2025
3:15 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:32 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:34 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AMLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/10/2025
7:28 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:28 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:30 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:32 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:32 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:30 AM | Amylyx Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/04/2025
5:24 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
5:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
5:14 AM | Amylyx Pharmaceuticals (Filer)
| Form POSASR | |
02/26/2025
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
7:17 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:54 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:55 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:58 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:55 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:53 PM | Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/10/2025
4:13 PM | Amylyx Pharmaceuticals (Filer)
| Form 424B5 | |
01/10/2025
4:23 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
5:05 AM | Amylyx Pharmaceuticals (Filer)
| Form 424B5 | |
01/08/2025
4:29 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
4:26 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:50 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
4:21 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:24 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
9:56 AM | Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/25/2024
4:38 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/17/2024
8:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
What President Trump’s Executive Order 14154 means for your money (Ad) Nearly $3 trillion disappeared from the stock market on Thursday morning.
According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard. But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi |
10/02/2024
5:48 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:50 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
4:56 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:39 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:30 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:55 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4/A | |
09/05/2024
6:26 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
5:49 PM | Amylyx Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
08/08/2024
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:14 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
06/21/2024
4:07 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:42 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:49 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:52 PM | Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:36 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:37 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:05 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
